Concepedia

Inhibition of platelet function by abciximab or high-dose tirofiban in patients with STEMI undergoing primary PCI: a randomised trial

Jochem W. van Werkum, Wim B. Gerritsen, Johannes C. Kelder, C. M. Hackeng, Sabine Ernst, Vera H.M. Deneer, Maarten-Jan Suttorp, B. J. W. M. Rensing, H. W. M. Plokker, J M Ten Berg

Netherlands Heart Journal · 2007 · 24 citations · 19 references

DOIFull text

Open access

Concepts

References

19

Use of a Monoclonal Antibody Directed against the Platelet Glycoprotein IIb/IIIa Receptor in High-Risk Coronary Angioplasty

The EPIC Investigators · New England Journal of Medicine · 1994 · 2.6K citations · Full text

, , +17

Comparison of Angioplasty with Stenting, with or without Abciximab, in Acute Myocardial Infarction

Gregg W. Stone, Cindy L. Grines, David A. Cox et al. · New England Journal of Medicine · 2002 · 1.3K citations · Full text

, , +14

Platelet Glycoprotein IIb/IIIa Inhibition with Coronary Stenting for Acute Myocardial Infarction

Gilles Montalescot, Paul Barragan, Olivier Wittenberg et al. · New England Journal of Medicine · 2001 · 1.2K citations · Full text

, , +14

Long-Term Benefit of Primary Angioplasty as Compared with Thrombolytic Therapy for Acute Myocardial Infarction

Felix Zijlstra, Jan C.A. Hoorntje, Menko‐Jan de Boer et al. · New England Journal of Medicine · 1999 · 718 citations

, , +11

Comparison of Two Platelet Glycoprotein IIb/IIIa Inhibitors, Tirofiban and Abciximab, for the Prevention of Ischemic Events with Percutaneous Coronary Revascularization

Eric J. Topol, David J. Moliterno, Howard C. Herrmann et al. · New England Journal of Medicine · 2001 · 681 citations · Full text

, , +16